Tag: Dr Jonathan Hourihane

AR101

Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...

AR101-Treated Patients Who Completed PALISADE Had 95% Increased Probability of Tolerating Any Dose of Peanut Protein in Exit Challenge Compared to Placebo.

Connect with Us

39,581FansLike
863FollowersFollow
2,737FollowersFollow
5,564FollowersFollow
41SubscribersSubscribe